These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 38345233)

  • 21. [Treatment of gamma-hydroxybutyrate withdrawal].
    Strand NAW; Petersen TS; Nielsen LM; Boegevig S
    Ugeskr Laeger; 2017 Dec; 179(50):. PubMed ID: 29260701
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Baclofen to Prevent Relapse in Gamma-Hydroxybutyrate (GHB)-Dependent Patients: A Multicentre, Open-Label, Non-Randomized, Controlled Trial.
    Beurmanjer H; Kamal RM; de Jong CAJ; Dijkstra BAG; Schellekens AFA
    CNS Drugs; 2018 May; 32(5):437-442. PubMed ID: 29651711
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics and pharmacodynamics of γ-hydroxybutyrate in healthy subjects.
    Liechti ME; Quednow BB; Liakoni E; Dornbierer D; von Rotz R; Gachet MS; Gertsch J; Seifritz E; Bosch OG
    Br J Clin Pharmacol; 2016 May; 81(5):980-8. PubMed ID: 26659543
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Within-patient variability in clinical presentation of gamma-hydroxybutyrate withdrawal: a case report.
    Glasper A; McDonough M; Bearn J
    Eur Addict Res; 2005; 11(3):152-4. PubMed ID: 15990433
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Withdrawal syndrome following chronic use of gamma-hydroxybutyric acid (GHB)].
    Moitroux A; Kestens C
    Rev Med Liege; 2023 Jul; 78(7-8):451-455. PubMed ID: 37560960
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phenobarbital to manage severe gamma-hydroxybutyrate withdrawal: A case series.
    Freeman G; Siefried KJ; Roberts DM; Rodgers C; Nic Ionmhain U; Ramanathan J; Ezard N; Brett J
    Drug Alcohol Rev; 2023 Jan; 42(1):27-32. PubMed ID: 36269081
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gamma hydroxybutyrate (GHB) and gamma butyrolactone (GBL) withdrawal: five case studies.
    McDaniel CH; Miotto KA
    J Psychoactive Drugs; 2001; 33(2):143-9. PubMed ID: 11476261
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Withdrawal syndrome after abuse of GHB (Gamma-Hydroxybutyrate) and its physiological precursors - its relevance for child and adolescent psychiatrists].
    Zepf FD; Holtmann M; Duketis E; Maier J; Radeloff D; Schirman S; Wagner A; Poustka F; Wöckel L
    Z Kinder Jugendpsychiatr Psychother; 2009 Sep; 37(5):413-20. PubMed ID: 19739059
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gamma-hydroxybutyrate detoxification by titration and tapering.
    de Jong CA; Kamal R; Dijkstra BA; de Haan HA
    Eur Addict Res; 2012; 18(1):40-5. PubMed ID: 22142784
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The abrupt cessation of therapeutically administered sodium oxybate (GHB) does not cause withdrawal symptoms.
    J Toxicol Clin Toxicol; 2003; 41(2):131-5. PubMed ID: 12733850
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Baclofen in gamma-hydroxybutyrate withdrawal: patterns of use and online availability.
    Floyd CN; Wood DM; Dargan PI
    Eur J Clin Pharmacol; 2018 Mar; 74(3):349-356. PubMed ID: 29198063
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gamma-hydroxybutyrate withdrawal syndrome.
    Dyer JE; Roth B; Hyma BA
    Ann Emerg Med; 2001 Feb; 37(2):147-53. PubMed ID: 11174231
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sodium Oxybate Therapy for Alcohol Withdrawal Syndrome and Keeping of Alcohol Abstinence.
    Mannucci C; Pichini S; Spagnolo EV; Calapai F; Gangemi S; Navarra M; Calapai G
    Curr Drug Metab; 2018; 19(13):1056-1064. PubMed ID: 29219048
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Hypernatremia caused by treatment with GHB obtained via a doctor's prescription].
    Rood IM; Seijger CG; van Waarde JA; de Maat MM; Verhave JC; Blans MJ
    Tijdschr Psychiatr; 2017; 59(1):47-51. PubMed ID: 28098924
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Gamma-hydroxybutyric acid (GHB) dependence and the GHB withdrawal syndrome: diagnosis and treatment].
    van Noorden MS; Kamal R; de Jong CA; Vergouwen AC; Zitman FG
    Ned Tijdschr Geneeskd; 2010; 154():A1286. PubMed ID: 21040601
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gamma hydroxybutyric acid (GHB) intoxication.
    Mason PE; Kerns WP
    Acad Emerg Med; 2002 Jul; 9(7):730-9. PubMed ID: 12093716
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gamma-Hydroxybutyrate (GHB) Withdrawal in a Patient with Polysubstance Use.
    Bernstein A
    J Psychoactive Drugs; 2021; 53(4):299-301. PubMed ID: 33357048
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Life threatening symptoms of withdrawal of gamma-hydroxybutyrate].
    Veerman SR; Dijkstra HN; Liefting-Kluft I
    Tijdschr Psychiatr; 2010; 52(6):411-6. PubMed ID: 20544599
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Withdrawal from gamma-hydroxybutyrate, 1,4-butanediol and gamma-butyrolactone: a case report and systematic review.
    Wojtowicz JM; Yarema MC; Wax PM
    CJEM; 2008 Jan; 10(1):69-74. PubMed ID: 18226321
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gamma-hydroxybutyrate: an emerging drug of abuse that causes physical dependence.
    Galloway GP; Frederick SL; Staggers FE; Gonzales M; Stalcup SA; Smith DE
    Addiction; 1997 Jan; 92(1):89-96. PubMed ID: 9060200
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.